Shanghai Tofflon Science Tech (300171) - Total Assets
Based on the latest financial reports, Shanghai Tofflon Science Tech (300171) holds total assets worth CN¥13.30 Billion CNY (≈ $1.95 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 300171 total equity for net asset value and shareholders' equity analysis.
Shanghai Tofflon Science Tech - Total Assets Trend (2007–2024)
This chart illustrates how Shanghai Tofflon Science Tech's total assets have evolved over time, based on quarterly financial data.
Shanghai Tofflon Science Tech - Asset Composition Analysis
Current Asset Composition (December 2024)
Shanghai Tofflon Science Tech's total assets of CN¥13.30 Billion consist of 74.0% current assets and 26.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 19.2% |
| Accounts Receivable | CN¥2.16 Billion | 16.5% |
| Inventory | CN¥3.27 Billion | 25.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥283.15 Million | 2.2% |
| Goodwill | CN¥199.08 Million | 1.5% |
Asset Composition Trend (2007–2024)
This chart illustrates how Shanghai Tofflon Science Tech's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Shanghai Tofflon Science Tech market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai Tofflon Science Tech's current assets represent 74.0% of total assets in 2024, a decrease from 81.6% in 2007.
- Cash Position: Cash and equivalents constituted 19.2% of total assets in 2024, down from 31.1% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 6.0% in 2007.
- Asset Diversification: The largest asset category is inventory at 25.0% of total assets.
Shanghai Tofflon Science Tech Competitors by Total Assets
Key competitors of Shanghai Tofflon Science Tech based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.14 Billion |
|
Vizionfocus Inc.
TW:4771
|
Taiwan | NT$6.53 Billion |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Shanghai Tofflon Science Tech - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.01 | 2.03 | 2.07 |
| Quick Ratio | 1.34 | 1.31 | 1.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥5.07 Billion | CN¥5.00 Billion | CN¥3.03 Billion |
Shanghai Tofflon Science Tech - Advanced Valuation Insights
This section examines the relationship between Shanghai Tofflon Science Tech's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.63 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | 1.3% |
| Total Assets | CN¥13.07 Billion |
| Market Capitalization | $1.47 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai Tofflon Science Tech's assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Shanghai Tofflon Science Tech's assets grew by 1.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Shanghai Tofflon Science Tech (2007–2024)
The table below shows the annual total assets of Shanghai Tofflon Science Tech from 2007 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥13.07 Billion ≈ $1.91 Billion |
+1.32% |
| 2023-12-31 | CN¥12.90 Billion ≈ $1.89 Billion |
-3.58% |
| 2022-12-31 | CN¥13.38 Billion ≈ $1.96 Billion |
+37.34% |
| 2021-12-31 | CN¥9.74 Billion ≈ $1.43 Billion |
+48.03% |
| 2020-12-31 | CN¥6.58 Billion ≈ $962.83 Million |
+26.33% |
| 2019-12-31 | CN¥5.21 Billion ≈ $762.18 Million |
+11.10% |
| 2018-12-31 | CN¥4.69 Billion ≈ $686.01 Million |
+7.37% |
| 2017-12-31 | CN¥4.37 Billion ≈ $638.92 Million |
+4.01% |
| 2016-12-31 | CN¥4.20 Billion ≈ $614.30 Million |
+3.34% |
| 2015-12-31 | CN¥4.06 Billion ≈ $594.43 Million |
-2.54% |
| 2014-12-31 | CN¥4.17 Billion ≈ $609.91 Million |
+10.31% |
| 2013-12-31 | CN¥3.78 Billion ≈ $552.92 Million |
+17.66% |
| 2012-12-31 | CN¥3.21 Billion ≈ $469.95 Million |
+27.52% |
| 2011-12-31 | CN¥2.52 Billion ≈ $368.52 Million |
+201.73% |
| 2010-12-31 | CN¥834.65 Million ≈ $122.14 Million |
+54.91% |
| 2009-12-31 | CN¥538.80 Million ≈ $78.84 Million |
+49.33% |
| 2008-12-31 | CN¥360.80 Million ≈ $52.80 Million |
+35.06% |
| 2007-12-31 | CN¥267.15 Million ≈ $39.09 Million |
-- |
About Shanghai Tofflon Science Tech
Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laborato… Read more